CorNatural
Latest round
- Seed
Last raised
- Aug 2019
Total raised
- Undisclosed
Investors
- 2
About CorNatural
CorNatural specializes in synthetic biology and genetic engineering solutions. Founded in 2019 in London, UK, by Paulo Puterman, the company has completed one significant deal as of August 13, 2019.CorNatural focuses on innovative solutions using synthetic biology and genetic engineering to reduce healthcare costs.CorNatural generates revenue through partnerships and direct transactions within the healthcare sector, developing tailored solutions for clients based on value-driven pricing. The company aims to design new solutions targeted for launch in the upcoming years while exploring opportunities for expansion into additional markets in Europe and North America by 2023.
Who invested in CorNatural
2 investors across 1 round
See all investors in CorNatural
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 13, 2019
Amount
Undisclosed
Investors
Questions about CorNatural
Who invested in CorNatural?
CorNatural has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CorNatural raised?
CorNatural has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CorNatural last raise money?
CorNatural's most recent round on record is a Seed, in Aug 2019.
What does CorNatural do?
CorNatural specializes in synthetic biology and genetic engineering solutions.
Where is CorNatural headquartered?
CorNatural is headquartered in London, UK.
Which VCs invest in companies like CorNatural?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back consumer products companies at CorNatural's stage. Their profiles are linked below.
VCs backing consumer products startups at Seed
Raising like CorNatural? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.